Search

everythinglearnresearchcommunity

for

Search:↓

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

People with androgenetic alopecia may have higher cholesterol and triglycerides, suggesting a higher risk of heart disease.

IL-4 gene variation may increase the risk of alopecia areata in Turkish people.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

PRP, especially AA-PRP, can help improve hair growth in androgenetic alopecia.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Alopecia areata may increase the risk of cardiovascular disease.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The 736T>A mutation in the LIPH gene is common in Japanese people with autosomal recessive woolly hair.

Antibody treatments show promise for hair loss but need more research.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Nanoparticles with specific drugs can help regrow hair in alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

PRDX5 enzyme may contribute to alopecia areata by affecting oxidative stress and autoimmunity.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Restoring hair follicle immune privilege may help treat alopecia areata.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

IL-27 can prevent hair loss in alopecia areata.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.